Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A modified staging classification for cutaneous T-cell lymphoma.

M Kashani-Sabet1, A McMillan, H S Zackheim

  • 1Cutaneous Oncology Division, University of California San Francisco Cancer Center, 4th Floor, 1600 Devisadero Street, San Francisco, CA 94115, USA.

Journal of the American Academy of Dermatology
|October 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of identifying proliferative active bone marrow with fat fraction MRI and multi-energy CT.

Physics in medicine and biology·2024
Same author

Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.

British journal of haematology·2023
Same author

CAR T in patients with large B-cell lymphoma not fit for autologous transplant.

British journal of haematology·2023
Same author

A survey of current burns knowledge in UK undergraduate medical students.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2020
Same author

The public's perception of firework safety and proposed use of graphic warning images on packaging.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2019
Same author

Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair.

Science advances·2019
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Journal of the American Academy of Dermatology·2026
Same journal

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Journal of the American Academy of Dermatology·2026
Same journal

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Journal of the American Academy of Dermatology·2026
Same journal

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal of the American Academy of Dermatology·2026
See all related articles

A revised staging system for cutaneous T-cell lymphoma (CTCL) improves prognostic assessment. This new classification for mycosis fungoides and Sézary syndrome better predicts patient survival than the current standard.

Area of Science:

  • Dermatology
  • Oncology
  • Clinical Pathology

Background:

  • Current staging for cutaneous T-cell lymphoma (CTCL), specifically mycosis fungoides and Sézary syndrome, has remained unchanged since 1979.
  • Despite diagnostic advancements, the existing CTCL staging system lacks prognostic refinement.

Purpose of the Study:

  • To review the established staging criteria for CTCL.
  • To evaluate the efficacy of a novel staging scheme for mycosis fungoides and Sézary syndrome.

Main Methods:

  • Overall survival data from 450 patients diagnosed with mycosis fungoides or Sézary syndrome were analyzed.
  • Survival rates were compared between the current staging system and a modified classification.

Main Results:

Related Experiment Videos

  • No significant survival differences were observed between current stages IB/IIA and IIB/III.
  • A significant survival disparity was found between patients with extensive patch versus extensive plaque disease.
  • The modified staging, differentiating T2 into patch/plaque and grouping tumors/erythroderma into stage III, demonstrated superior survival prediction.

    • Conclusions:

    • Modifying the current CTCL staging classification creates clinically relevant subgroups.
    • The revised staging system offers improved prognostic assessment for patients with CTCL.